Article Text

other Versions

PDF
Systematic review
Guidelines on glucose self-monitoring in non-insulin users are not evidence-based
  1. Julienne K Kirk
  1. Department of Family & Community Medicine, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA
  1. Correspondence to Julienne K Kirk
    Department of Family & Community Medicine, Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157, USA, jkirk{at}wfubmc.edu

Statistics from Altmetric.com

Commentary on: OpenUrlCrossRefPubMed

Context

There is controversy over the use of self-monitoring blood glucose (SMBG) in patients with type 2 diabetes mellitus (T2DM) not taking insulin. SMBG for patients taking insulin is supported by necessity to closely monitor glucose and potential fluctuations. Many individuals with T2DM use SMBG to guide treatment decisions while others use SMBG to fulfil clinician recommendations to check blood glucose levels. Since many patients with T2DM are not always prone to hypoglycaemia, the utility of the frequent testing is debatable. In addition, the financial implications of SMBG can be tremendous, and SMBG may reduce quality of life. Third party payers will not always support SMBG with high frequency testing in T2DM non-insulin users. Aakre and colleagues examine SMBG in non-insulin T2DM with regard to recommendations put forth by clinical …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.